EFFECT OF A SUBSTANCE P ANTAGONIST ON THE SECRETION OF ALDOSTERONE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME AND ARTERIAL HYPERTENSION

Abroad (travel likely)RecruitingPHASE2

Conditions

Apnea, Obstructive

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CHU de Rouen, Rouen, France, France
Contact: Study coordinator (Antoine-Guy Lopez) · Antoine-Guy.Lopez@chu-rouen.fr · Antoine-Guy.Lopez@chu-rouen.fr

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Benefits of Oxytocin in Obstructive Sleep Apnea (OSA) Patients Using Continuous Positive Airway Pressure (CPAP) Machine

Sleep Apnea · Sleep Apnea, Obstructive

Abroad (travel likely)RecruitingPHASE1

Washington D.C., United States

Impact of the Mandibular Advancement Device on Sleep Apnea During CPAP Withdrawal

Sleep Apnea, Obstructive · Endothelial Dysfunction

Abroad (travel likely)Recruiting

Angers, France

The REPOSE (Reach for Equity in Pediatric Sleep Evaluation) Navigation Intervention

Sleep Apnea, Obstructive

Abroad (travel likely)Recruiting

Charleston, United States

Accuracy of the Sensory Test Using the Laryngopharyngeal Endoscopic Esthesiometer in Obstructive Sleep Apnea

Sleep Apnea, Obstructive · Larynx · Sensory Disorder

Abroad (travel likely)Recruiting

Bogotá, Colombia · Chía, Colombia